Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Advances in Biological Regulation is Scopus-indexed (Q2, CiteScore 5.3), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 2212-4926Verify ISSN ↗2212-4934Verify ISSN ↗
Publisher: Elsevier Ltd
Cost to publish: About US$3,530 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics | 145 / 357 | 59th | Q2 |
| Cancer Research | 118 / 233 | 49th | Q3 |
| Molecular Biology | 214 / 414 | 48th | Q3 |
| Molecular Medicine | 95 / 179 | 47th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q2, CiteScore 5.3.
Advances in Biological Regulation is Q2 in Genetics (rank 145 of 357), Q3 in Cancer Research (rank 118 of 233) and Q3 in Molecular Biology (rank 214 of 414), by CiteScore 2025. It is ranked in 4 subject areas in all.
Advances in Biological Regulation is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.3, which places it in quartile Q2 at the 59th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.894, quartile Q2, with an H-index of 75.
The publisher lists an article processing charge of about US$3,530 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Advances in Biological Regulation is published by Elsevier Ltd. Its print ISSN is 2212-4926 and its online ISSN is 2212-4934.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Advances in Biological Regulation has an h-index of 69 and a 2-year mean of 2.13 citations per paper (OpenAlex). Its Scopus CiteScore is 5.3, quartile Q2. On 2-year citations it ranks #204 of 353 Scopus journals in Genetics.
Advances in Biological Regulation published 41 papers in 2025; its busiest recent year was 2017 with 55. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 83 research articles (2023–2026), authors are most often from United States (31.6%), Japan (12%) and Italy (11.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.